Novel high-throughput myofibroblast assays identify agonists with therapeutic potential in pulmonary fibrosis that act via EP2 and EP4 receptors.
- DOI
- 10.1371/journal.pone.0207872
- Published
- 2018
- Container
- PloS one
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1371/journal.pone.0207872,
title = {Novel high-throughput myofibroblast assays identify agonists with therapeutic potential in pulmonary fibrosis that act via EP2 and EP4 receptors.},
author = {Sieber P and Schäfer A and Lieberherr R and Le Goff F and Stritt M and Welford RWD and Gatfield J and Peter O and Nayler O and Lüthi U},
year = {2018},
journal = {PloS one},
doi = {10.1371/journal.pone.0207872},
url = {https://doi.org/10.1371/journal.pone.0207872}
}RIS
TY - JOUR TI - Novel high-throughput myofibroblast assays identify agonists with therapeutic potential in pulmonary fibrosis that act via EP2 and EP4 receptors. AU - Sieber P AU - Schäfer A AU - Lieberherr R AU - Le Goff F AU - Stritt M AU - Welford RWD AU - Gatfield J AU - Peter O AU - Nayler O AU - Lüthi U PY - 2018 JO - PloS one DO - 10.1371/journal.pone.0207872 UR - https://doi.org/10.1371/journal.pone.0207872 ER -
APA
P, S., A, S., R, L., F, L. G., M, S., RWD, W., J, G., O, P., O, N., & U, L. (2018). Novel high-throughput myofibroblast assays identify agonists with therapeutic potential in pulmonary fibrosis that act via EP2 and EP4 receptors.. PloS one. https://doi.org/10.1371/journal.pone.0207872
Source records
- pubmed · retrieved 2026-09-25T07:25:05.848Z